Regulus Therapeutics Inc (RGLS) Return on Investment ROI from the first quarter of 2025 to first quarter of 2024 and for the year 2025, average high and low, overall ranking from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Regulus Therapeutics Inc   (NASDAQ: RGLS)


Regulus Therapeutics Inc's ROI from its first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Regulus Therapeutics Inc's ROI in the first quarter of 2025?
Regulus Therapeutics Inc recorded a cumulative net loss of $-48 million during 12 months ending in the first quarter of 2025, resulting in a negative return on investment (ROI) of -57.04%.

Within the Healthcare sector 583 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2025 quarter, so far to 3978, from total ROI ranking in the fourth quarter of 2024 at 4540.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Investment Change TTM 70.36 % 221.86 % 147.2 % 84.67 % 27.58 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 70 77 87 99 108
Return On Investment (TTM) -57.04 % -49.94 % -52.55 % -54.65 % -64.14 %
RGLS's Overall Ranking # 3978 # 4540 # 4046 # 4099 # 4265
Seq. Investment Change TTM -10.24 % 17.18 % 22.31 % 32.43 % 69.58 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -48 -46 -42 -35 -31

RGLS Company Profile >> Back to RGLS Roi Comparisons >> See Annual RGLS Return On Investment



Return On Investment RGLS's Ranking
Within: No.
Industry # 258
Sector # 584
Overall # 3978

Return On Investment Statistics
High Average Low
-19.27 %
-207.83 %
-4618.67 %
(Dec 31 2013)   (Sep 30 2019)







Financial Statements
Regulus Therapeutics Inc's I. Quarter Investments $ 70 Millions RGLS's Balance sheet
Regulus Therapeutics Inc's I. Quarter Income $ -10 Millions Quarterly RGLS's Income Statement
RGLS's Income by Division See RGLS's Income by Division


RGLS Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 77 22 35 63 26
Y / Y Investment Growth 244.76 % -36.56 % -44.55 % 140.33 % 28.44 %
Net Income in Millions -46 -30 -28 -28 -16
Y / Y Net Income Growth - - - - -
Annual Return On Investment -60.45 % -135.05 % -80.79 % -43.98 % -59.79 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RGLS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RGLS's Competitors
Subscribers only: Roi for Regulus Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for RGLS's Customers

Other Ratios
RGLS's Roa RGLS's Inventory Turnover Ratio RGLS's Growth Rates RGLS's Dividend Statistics
RGLS's Profitability Ratios RGLS's Asset Turnover Ratio RGLS's Dividend Growth
RGLS's Roe RGLS's Valuation Ratios RGLS's Financial Strength Ratios RGLS's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2025, within Healthcare Sector ROI

Date modified: 2026-09-26T07:09:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.